Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.65 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 2/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1253728 | 1.00 | SLC7A5 (0.65) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| SCHEMBL4453960 | 0.91 | SLC7A5 (0.67) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| SCHEMBL27680265 | 0.91 | SLC7A5 (0.67) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| SCHEMBL28698329 | 0.87 | SLC7A5 (0.62) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| SCHEMBL28698332 | 0.87 | SLC7A5 (0.62) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| SCHEMBL27967418 | 0.86 | SLC7A5 (0.66) | SLC7A5TAAR1SLC6A2HDAC8ESR1 | |
| SCHEMBL4279625 | 0.86 | SLC7A5 (0.61) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| SCHEMBL321221 | 0.86 | SLC7A5 (0.61) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| Pyruvate SCHEMBL4082845 | 0.85 | SLC7A5 (0.53) | SLC7A5TAAR1SLC6A2HDAC8DPP4 | |
| SCHEMBL23243815 | 0.85 | SLC7A5 (0.46) | SLC7A5DPP4ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3333261-B1 | HEXURONATE C4-EPIMERASE VARIANT WITH IMPROVED D-TAGATOSE PRODUCTION ACTIVITY, AND D-TAGATOSE PRODUCTION METHOD USING SAME | CJ CHEILJEDANG CORP (KR) | 2023-11-15 | — | — | EP | claimed |
| EP-3710594-B1 | METHODS TO MEASURE FUNCTIONAL HETEROGENEITY AMONG SINGLE CELLS | UNIV COLORADO REGENTS (US) | 2023-07-19 | — | — | EP | claimed |
| EP-3911354-B1 | AAV-MEDIATED GENE THERAPY RESTORING THE OTOFERLIN GENE | PASTEUR INSTITUT (FR) | 2023-07-19 | — | — | EP | claimed |
| CN-114377154-B | X-ray fluorescence and fluorescence bimodal imaging probe based on synchrotron radiation light source, preparation method and application | 中国科学院上海高等研究院 | 2023-07-07 | — | — | CN | claimed |
| US-20230105024-A1 | Bifunctional C-Glycoside Glycosyltransferases and Application Thereof | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2023-04-06 | — | — | US | claimed |
| US-20230066984-A1 | New Carbon Glycoside Glycosyltransferase and Use Thereof | CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES (CN) | 2023-03-02 | — | — | US | claimed |
| CN-115552013-A | Modified micronucleus core proteins and their use in nucleic acid delivery | 加总生物公司 | 2022-12-30 | — | — | CN | claimed |
| EP-4108777-A1 | BIFUNCTIONAL C-GLYCOSIDE GLYCOSYLTRANSFERASES AND APPLICATION THEREOF | CAS Center for Excellence in Molecular Plant Sciences (CN) | 2022-12-28 | — | — | EP | claimed |
| US-20220396611-A1 | FACTOR VIII CONSTRUCT | SPUR THERAPEUTICS LIMITED (GB) | 2022-12-15 | — | — | US | claimed |
| CN-114929735-A | Factor VIII constructs | 自由行疗法有限公司 | 2022-08-19 | — | — | CN | claimed |
| EP-0804484-A1 | ANTIGENIC POLYPEPTIDE SEQUENCE OF FACTOR VIII, FRAGMENTS AND/OR EPITOPES THEREOF | CROIX ROUGE DE BELGIQUE (BE) | 1997-11-05 | — | — | EP | claimed |
| US-5674703-A | CONSISTING OF PAPILLOMA VIRUS ORIGIN OF REPLICATION, FIRST PROMOTER TRANSCRIPTIONALLY LINKED TO DNA SEQUENCE, SECOND PROMOTER LINKED TO PAPILLOMA VIRUS E1 GENE SEQUENCE, THIRD PROMOTER LINKED TO PAPILLOMA VIRUS E2 GENE SEQUENCE | BAYLOR COLLEGE OF MEDICINE | 1997-10-07 | — | — | US | claimed |
| WO-1996002572-A2 | ANTIGENIC POLYPEPTIDE SEQUENCE OF FACTOR VIII, FRAGMENTS AND/OR EPITOPES THEREOF | CROIX-ROUGE DE BELGIQUE (BE) | 1996-02-01 | — | — | WO | claimed |
| WO-1994012629-A1 | EPISOMAL VECTORS FOR GENE THERAPY | BAYLOR COLLEGE OF MEDICINE (US) | 1994-06-09 | — | — | WO | claimed |
| EP-0375040-B1 | Process for the preparation of retro-inverso peptides and new intermediates thereof | SCLAVO SPA (IT) | 1994-03-16 | — | — | EP | claimed |
| EP-0134631-B1 | PEPTIDES, PHARMACEUTICAL COMPOSITIONS, GENES, VECTORS, HOST ORGANISMS, PROCESSES FOR THEIR PRODUCTION AND DIAGNOSTIC REAGENTS | CELLTECH LIMITED (GB) | 1991-04-03 | — | — | EP | claimed |
| EP-0089365-A4 | New Dye or Fluorescent polymers and their use as labels in immunoassay systems. | HENRY ROBERT P | 1985-08-21 | — | — | EP | claimed |
| US-4452886-A | Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems | PHOTEST DIAGNOSTICS, INC. A CORPORATION OF DE | 1984-06-05 | — | — | US | claimed |
| EP-0089365-A1 | New Dye or Fluorescent polymers and their use as labels in immunoassay systems. | PHOTEST DIAGNOSTICS, INC. (US) | 1983-09-28 | — | — | EP | claimed |
| WO-1983001064-A1 | NOVEL PHOTON ABSORBING OR EMITTING POLYMERS AND THEIR USE AS REAGENTS IN IMMUNOASSAY SYSTEMS | HENRY, ROBERT, P. | 1983-03-31 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230066984-A1 | New Carbon Glycoside Glycosyltransferase and Use Thereof | UGGT1, UGDH, UGCG | SLC7A5 1880/4885TAAR1 4843/4885SLC6A2 1136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.